Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective

Background In phenylketonuria (PKU), modified casein glycomacropeptide supplements (CGMP-AA) are used as an alternative to the traditional phenylalanine (Phe)-free L-amino acid supplements (L-AA). However, studies focusing on the long-term nutritional status of CGMP-AA are lacking. This retrospectiv...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pena, MJ (author)
Outros Autores: Pinto, A (author), de Almeida, MF (author), Barbosa, CD (author), Ramos, PC (author), Rocha, S (author), Guimas, A (author), Ribeiro, R (author), Martins, E (author), Bandeira, A (author), Dias, CC (author), MacDonald, A (author), Borges, Nuno (author), Rocha, JC (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
Ciências da Saúde, Ciências médicas e da saúde
Health sciences, Medical and Health sciences
Texto completo:https://hdl.handle.net/10216/135302
País:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/135302

Texto Completo

https://hdl.handle.net/10216/135302

Registos relacionados